The current valuation score of Achieve Life Sciences Inc is 9.73, ranking 11 out of 377 in the Biotechnology & Medical Research industry. Its current P/E ratio is -7.30, which is -91.47% below the recent high of -0.62 and -8.80% above the recent low of -7.94.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.